MACOMICS Trademark

Trademark Overview


On Thursday, February 11, 2021, a trademark application was filed for MACOMICS with the United States Patent and Trademark Office. The USPTO has given the MACOMICS trademark a serial number of 79310228. The federal status of this trademark filing is REGISTERED as of Tuesday, June 28, 2022. This trademark is owned by Macomics Ltd. The MACOMICS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Scientific and technological services, namely research and design in the field of medicine and medical therapies; medical research and pharmacological research services; medical laboratory services; medical research laboratory services; research and development of medicines, pharmaceuticals, drugs and medical treatments; research into and development of medical therapies; research into and development of immunotherapies; research into and development of medical therapies that modulate macrophages; research into and development of medical therapies that increase the body's immune defence against tumours; medical scientific research services relating to the discovery, preclinical and clinical development of therapeutic products; research into and development of cancer and tumour treatments; research and development services in the field of oncology; consultancy, advice and information for the aforesaid services
macomics

General Information


Serial Number79310228
Word MarkMACOMICS
Filing DateThursday, February 11, 2021
Status700 - REGISTERED
Status DateTuesday, June 28, 2022
Registration Number6770076
Registration DateTuesday, June 28, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 12, 2022

Trademark Statements


Goods and ServicesScientific and technological services, namely research and design in the field of medicine and medical therapies; medical research and pharmacological research services; medical laboratory services; medical research laboratory services; research and development of medicines, pharmaceuticals, drugs and medical treatments; research into and development of medical therapies; research into and development of immunotherapies; research into and development of medical therapies that modulate macrophages; research into and development of medical therapies that increase the body's immune defence against tumours; medical scientific research services relating to the discovery, preclinical and clinical development of therapeutic products; research into and development of cancer and tumour treatments; research and development services in the field of oncology; consultancy, advice and information for the aforesaid services

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, May 11, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameMacomics Ltd
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressGB

Party NameMacomics Ltd
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressGB

Party NameMacomics Ltd
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGB

Trademark Events


Event DateEvent Description
Tuesday, November 1, 2022FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, October 7, 2022FINAL DISPOSITION NOTICE SENT TO IB
Friday, October 7, 2022FINAL DISPOSITION PROCESSED
Wednesday, September 28, 2022FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, June 28, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, June 28, 2022REGISTERED-PRINCIPAL REGISTER
Tuesday, April 12, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 12, 2022PUBLISHED FOR OPPOSITION
Wednesday, March 23, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, March 10, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 2, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, March 2, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, March 2, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, October 25, 2021REFUSAL PROCESSED BY IB
Monday, September 27, 2021NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, September 27, 2021REFUSAL PROCESSED BY MPU
Tuesday, September 14, 2021NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, September 13, 2021NON-FINAL ACTION WRITTEN
Wednesday, September 8, 2021ASSIGNED TO EXAMINER
Saturday, May 15, 2021APPLICATION FILING RECEIPT MAILED
Tuesday, May 11, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, May 8, 2021SN ASSIGNED FOR SECT 66A APPL FROM IB